Clinical Trials Directory

Trials / Unknown

UnknownNCT04916821

Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Trabzon Kanuni Education and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Accepted

Summary

Primary purpose: To investigate the effect of propolis, a food supplement product, on healing parameters in patients with COVID 19. Secondary purpose: To provide a new supportive treatment in Covid 19 treatment. In the present study to examine the effect of the use of propolis on healing parameters (laboratory and imaging) in patients with COVID 19; Propolis, which has antiviral properties, has also been used in humans in the COVID19 pandemic as of 2020. However, in these studies, an alcohol-soluble extract of propolis was used. Despite the disadvantages of its use in alcohol, it is clear that water and olive oil extracts of Propolis are safer for humans. Therefore, water extracts of propolis will be used in the study.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTpropolisPropolis may be blocked virus entry to cells, and some receptor binding and some cell signal molecules

Timeline

Start date
2021-05-15
Primary completion
2021-07-15
Completion
2021-08-15
First posted
2021-06-08
Last updated
2021-06-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04916821. Inclusion in this directory is not an endorsement.